News
A new cancer vaccine targeting KRAS gene mutations shows promise in preventing pancreatic and colorectal cancer recurrence in ...
A new study reveals promising results for a vaccine targeting colorectal and pancreatic cancers. Researchers from the ...
Eredivisie history was written in Velsen-Zuid when PEC Zwolle midfielder Jadiel Pereira da Gama made his debut and thus ...
An 'off-the-shelf' vaccine may help prevent or delay cancer recurrence in people with hard-to-treat colorectal or pancreatic ...
New clinical data reveals promising efficacy of VS-7375, a KRAS G12D inhibitor, in advanced lung cancer, highlighting its ...
The ELI-002 2P vaccine uses peptides to train the immune system to spot and destroy cells with KRAS mutations.
Operator: Good morning, everyone, and welcome to the Edible Garden Incorporated 2025 Second Quarter Business Update ...
AbbVie unveiled a $195 million investment to expand active pharmaceutical ingredient manufacturing in the U.S. Bloomberg reported that BlinkRx, a company that has Donald Trump Jr. on its board, just ...
Dementia-like protein clumps found in pancreatic precancer mouse cells point to autophagy defects, offering cancer ...
A new research paper was published in Volume 16 of Oncotarget on August 13, 2025, titled “Clinical and analytical validation ...
A new vaccine aimed at a common cancer gene mutation could help stop aggressive pancreatic cancers from coming back.
Discover key insights from Edible Garden AG's Q2 2025 earnings call: strategic shifts, private label growth, new product launches, and bullish ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results